Table 2.
Overview of potency (EC50) and efficacy (Emax, relative to hydromorphone) values as obtained in the MOR activation assay. 95% confidence intervals are indicated between brackets.
| Emax (% of hydromorphone) | ||
|---|---|---|
| N-piperidinyl etonitazene reference standard | 2.49 (1.67–3.74) | 183 (173–194) |
| N-piperidinyl etonitazene sourced powder | 3.06 (2.19–4.26) | 180 (172–189) |
| Morphine | 134 (80.8–228) | 103 (96.2–109) |
| Fentanyl | 16.8 (11.7–24.4) | 147 (139–155) |
| Etonitazene | 0.370 (0.232–0.585) | 182 (171–193) |
| Hydromorphone | 23.2 (16.8–32.4) | 99.9 (95.1–105) |